AllianceBernstein’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

AllianceBernstein’s Portfolio CHTP Stock Details CHTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-49,230	Closed	-$272K	–	3883
2014 Q1	$272K	Buy	49,230 +38,822	+373%	+$195K	﹤0.01%	2659
2013 Q4	$46K	Sell	10,408 -17,661	-63%	-$59.7K	﹤0.01%	3005
2013 Q3	$84K	Sell	28,069 -5,679	-17%	-$16.3K	﹤0.01%	3001
2013 Q2	$78K	Buy	+33,748	New	+$68.2K	﹤0.01%	2969

Other funds holding CHTP

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

AllianceBernstein's CHTP Position: Q2 2014 in Review

AllianceBernstein sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 49,230 shares — an estimated $272K sold.

AllianceBernstein first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $272K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

AllianceBernstein reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
AllianceBernstein sold 49,230 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $272K.
AllianceBernstein first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
AllianceBernstein's CHELSEA THERAPEUTICS INT'L LTD position peaked at $272K in Q1 2014.
6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on AllianceBernstein's 13F filing for Q2 2014, filed 13 Aug 2014.